Ligandal, Inc
Ligandal is dedicated to accelerating precision medicine through advanced targeting technology. Their platform aims to give back time to patients, researchers, and healthcare providers by enabling targeted therapeutic delivery that addresses diseases at their molecular roots. With a focus on precision, personalization, and predictive medicine, Ligandal develops innovative solutions such as peptide direct conjugate (PDC) technology, LigandAI®, and Predictive Interactomics® to improve disease targeting and treatment efficacy.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Predictive peptide design platform (closed beta API)
A software platform offering predictive modeling for peptide-target interactions, peptide design automation, and binding affinity prediction accessible via API and developer tools.
Custom peptide-directed LNP conjugates
Targeted formulations combining client-supplied lipid nanoparticles with custom targeting peptides to improve tissue-specific delivery and uptake.
Predictive peptide design platform (closed beta API)
A software platform offering predictive modeling for peptide-target interactions, peptide design automation, and binding affinity prediction accessible via API and developer tools.
Custom peptide-directed LNP conjugates
Targeted formulations combining client-supplied lipid nanoparticles with custom targeting peptides to improve tissue-specific delivery and uptake.
Services
Design and manufacture of peptide-directed conjugates and targeted LNP conjugates to enable delivery of therapeutic payloads to specified tissues and cell types.
Programmatic access to a predictive design platform for peptide design, binding affinity prediction, and target analysis, provided as a closed beta with developer resources.
End-to-end service from AI-assisted peptide design to physical peptide synthesis and delivery, with stated rapid turnaround and quality controls.
Design and manufacture of peptide-directed conjugates and targeted LNP conjugates to enable delivery of therapeutic payloads to specified tissues and cell types.
Programmatic access to a predictive design platform for peptide design, binding affinity prediction, and target analysis, provided as a closed beta with developer resources.
End-to-end service from AI-assisted peptide design to physical peptide synthesis and delivery, with stated rapid turnaround and quality controls.
Expertise Areas
- Targeted drug delivery
- Peptide engineering and targeting
- Computational peptide design and predictive modeling
- LNP conjugation for targeted delivery
Key Technologies
- Peptide-directed conjugates (PDC)
- Lipid nanoparticle (LNP) conjugation
- Receptor-mediated endocytosis
- Endosomal escape mechanisms
News & Updates
Research Time Saved
Faster development with their custom targeting methodologies and Predictive Interactomics®.
Enabling Life-Saving Cures
95% of undrugged precision targets accessible, enabling cures for previously unreachable disease targets.
Research Time Saved
Faster development with their custom targeting methodologies and Predictive Interactomics®.
Enabling Life-Saving Cures
95% of undrugged precision targets accessible, enabling cures for previously unreachable disease targets.